Mechanisms Underlying Clinical Efficacy of Angiotensin II Type 2 Receptor (AT2R) Antagonist EMA401 in Neuropathic Pain: Clinical Tissue and in Vitro Studies

Title
Mechanisms Underlying Clinical Efficacy of Angiotensin II Type 2 Receptor (AT2R) Antagonist EMA401 in Neuropathic Pain: Clinical Tissue and in Vitro Studies
Authors
Keywords
Angiotensin II, AngIII, Ang-(1-7), AT<sub>2</sub>R, Antagonist, EMA401, Human DRG neurons, Peripheral nerve injury, Calcium imaging, Hypersensitivity, Neuropathic pain, Neurites
Journal
Molecular Pain
Volume 11, Issue -, Pages s12990-015-0038
Publisher
SAGE Publications
Online
2015-06-25
DOI
10.1186/s12990-015-0038-x

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started